Urigen completes 1:5000 reverse split and other changes: http://finance.yahoo.com/news/urigen-pharmaceuticals-announces-closing-restructuring-220337580.html The reverse split is academic insofar as the shares do not trade on any public exchange; from the above PR: The company's Stock previously traded under the designation (URGP.PK) on the OTC Markets. The Company's registration was revoked by the SEC in October, 2012, and there is no longer a public market for its securities, stockholders will be prohibited from transferring or selling their shares except in exempt transactions that are in compliance with the United States and applicable state securities laws. Shareholders who wish to effect any transfers or sales should consult with their own legal counsel to ensure compliance with all applicable law.